Q4 2025 Neuraxis Inc Earnings Call Transcript
Key Points
- Neuraxis Inc (NRXS) achieved a significant milestone by securing a Category 1 CPT code, effective January 1, 2026, which is expected to drive widespread sustainable growth.
- The company expanded its commercial footprint by securing a federal FSS contract, allowing sales within the Veterans Administration system.
- Neuraxis Inc (NRXS) reported a 27% increase in revenues for Q4 2025 compared to the same period in 2024, marking the sixth consecutive quarter of double-digit revenue growth.
- The company has successfully increased its covered lives to over 100 million, enhancing its reimbursement landscape and potential market reach.
- Neuraxis Inc (NRXS) is actively expanding its commercial team and infrastructure to support growth, including hiring medical science liaisons and market development specialists.
- Despite the progress, some hospitals with strong policy coverage have not yet reached expected utilization levels, indicating potential barriers to adoption.
- The company faces challenges in securing broad medical policy coverage for adult patients, which may require a large randomized controlled trial.
- Neuraxis Inc (NRXS) reported a net loss of $1.7 million for Q4 2025, an 18% increase compared to the same period in 2024, due to higher operating expenses.
- The gross margin for Q4 2025 decreased to 85.4% from 86.4% in Q4 2024, primarily due to reserves for excess and obsolete inventory and the growth of lower-margin products.
- The company acknowledges that policy changes and prior authorization improvements will unfold gradually, not overnight, which may delay immediate revenue impact.
Ladies and gentlemen, thank you for standing by. Welcome to the Neuraxis report fourth quarter 2025 financial results. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. (Operator Instructions) Please be advised that today's conference is being recorded.
I would like now to turn the conference over to Ben Shamsian, Investor relations. Please go ahead.
Thank you. Good morning, everyone, and thank you for joining us for Neraxis' 4th quarter and full year 2025 financial results and corporate update conference call. Joining us on the call today is Brian Krico, CEO of Neraxis, and Tim Hendricks, CFO of Neuraxis.
At the conclusion of today's prepared remarks, we will open the call to questions. If you are listening through the webcast, please follow the operator's instructions, or you can send me an e-mail at [email protected] with your questions. If you are dialed into the live phone, you can again
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
